Proteomic analysis of synovial fibroblast-like synoviocytes from rheumatoid arthritis. 2013

Xiao-Jun Li, and Min Xu, and Xiao-Qin Zhao, and Jian-Ning Zhao, and Fang-Fang Chen, and Wei Yu, and De-Yu Gao, and Bing Luo
School of Medicine, Nanjing University, Nanjing, China. lixiaojun62@yahoo.com.cn

OBJECTIVE The purpose of this study was to identity protein expression patterns of fibroblast-like synoviocytes (FLSs) derived from the synovial tissue of patients with rheumatoid arthritis (RA) and osteoarthritis. METHODS Two-dimensional gel electrophoresis (2-DE) in combination with matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF-MS) was used to visualise and identify differential cellular protein expression profiles in FLSs between RA and control groups. Western-blot analysis was performed to further verify selected differentially-expressed proteins. RESULTS A total of 1633 and 1603 protein spots were examined in synovial FLSs of RA patients and controls, respectively. Ninety-two spots in the RA group were statistically over- or under-expressed compared with controls. Among them, 33 proteins over-expressed by more than 3-fold were then identified by MALDI-TOF-MS analysis. These proteins included enzymatic and structural proteins (e.g. PKM1/M2, α-enolase, ERp60, lamin-A/C), signal transduction proteins (e.g. annexin 11, peroxiredoxin 1, TrpRS), heat-shock/chaperone proteins (e.g. TCP-1, GRP75, HspB5, Bip) and some unknown protein species. Three proteins, namely α-enolase, GRP75 and PKM2, were verified by Western blot and the results were found to be consistent with proteomic analysis. CONCLUSIONS The differentially expressed proteins identified in RA synovial FLSs might be candidate RA-associated proteins and may prove to be promising diagnostic indicators or new therapeutic targets for RA.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010003 Osteoarthritis A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans. Arthritis, Degenerative,Osteoarthrosis,Osteoarthrosis Deformans,Arthroses,Arthrosis,Arthritides, Degenerative,Degenerative Arthritides,Degenerative Arthritis,Osteoarthritides,Osteoarthroses
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D005260 Female Females
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013583 Synovial Membrane The inner membrane of a joint capsule surrounding a freely movable joint. It is loosely attached to the external fibrous capsule and secretes SYNOVIAL FLUID. Synovium,Membrana Synovialis Capsulae Articularis,Membrane, Synovial,Membranes, Synovial,Synovial Membranes

Related Publications

Xiao-Jun Li, and Min Xu, and Xiao-Qin Zhao, and Jian-Ning Zhao, and Fang-Fang Chen, and Wei Yu, and De-Yu Gao, and Bing Luo
June 2020, Nature reviews. Rheumatology,
Xiao-Jun Li, and Min Xu, and Xiao-Qin Zhao, and Jian-Ning Zhao, and Fang-Fang Chen, and Wei Yu, and De-Yu Gao, and Bing Luo
December 2022, Current opinion in pharmacology,
Xiao-Jun Li, and Min Xu, and Xiao-Qin Zhao, and Jian-Ning Zhao, and Fang-Fang Chen, and Wei Yu, and De-Yu Gao, and Bing Luo
November 2021, Scientific reports,
Xiao-Jun Li, and Min Xu, and Xiao-Qin Zhao, and Jian-Ning Zhao, and Fang-Fang Chen, and Wei Yu, and De-Yu Gao, and Bing Luo
April 2017, Epigenomics,
Xiao-Jun Li, and Min Xu, and Xiao-Qin Zhao, and Jian-Ning Zhao, and Fang-Fang Chen, and Wei Yu, and De-Yu Gao, and Bing Luo
January 2004, Arthritis research & therapy,
Xiao-Jun Li, and Min Xu, and Xiao-Qin Zhao, and Jian-Ning Zhao, and Fang-Fang Chen, and Wei Yu, and De-Yu Gao, and Bing Luo
January 2022, Frontiers in pharmacology,
Xiao-Jun Li, and Min Xu, and Xiao-Qin Zhao, and Jian-Ning Zhao, and Fang-Fang Chen, and Wei Yu, and De-Yu Gao, and Bing Luo
July 2002, International journal of molecular medicine,
Xiao-Jun Li, and Min Xu, and Xiao-Qin Zhao, and Jian-Ning Zhao, and Fang-Fang Chen, and Wei Yu, and De-Yu Gao, and Bing Luo
May 2018, Nature communications,
Xiao-Jun Li, and Min Xu, and Xiao-Qin Zhao, and Jian-Ning Zhao, and Fang-Fang Chen, and Wei Yu, and De-Yu Gao, and Bing Luo
January 2010, Immunological reviews,
Xiao-Jun Li, and Min Xu, and Xiao-Qin Zhao, and Jian-Ning Zhao, and Fang-Fang Chen, and Wei Yu, and De-Yu Gao, and Bing Luo
July 2011, Experimental biology and medicine (Maywood, N.J.),
Copied contents to your clipboard!